XNAS · CTSO
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Cytosorbents Corp.

Cytosorbents Corp.

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$0.3700
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
CTSO
Cytosorbents Corp.
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

43/ 100
Veridion Score
SELL BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CTSO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CTSO catalysts
About Cytosorbents Corp.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2005
Employees
129
Country
US

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.3700
Last session
Day high
$0.3700
Last session
Day low
$0.3700
Last session
Previous close
$0.3700
52W high
$0.9980
-62.93% from high
52W low
$0.3111
9% of range
Market cap
$23.3M
EPS
$-0.1700
Beta
1.65
Shares out
62.8M
Avg volume
79.1K
VWAP
$0.3700
Last session
Price history computed in-house
1W
-1.91%
1M
+2.78%
3M
-20.02%
1Y
-59.48%
YTD
-42.12%
SMA 50 $0.3876 · below
SMA 200 $0.5813 · below
52W position 9%

CTSO overview

Veridion Score
43
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CTSO.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CTSO Form 4 filings
Public disclosures

Congress activity in CTSO

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CTSO in the cached public ledger.

Federal contracts

CTSO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CTSO in this window.
Lobbying spend

CTSO lobbying filings, year to date.

Registered lobbying filings matched to Cytosorbents Corp..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CTSO in this window.
Loading news for CTSO
Analyst ratings
Sovereign unlock shows live analyst consensus for CTSO.
Options
Sovereign unlock shows live options positioning for CTSO.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.